Nexalin Technology
NXL
3 hedge funds and large institutions have $18.3K invested in Nexalin Technology in 2023 Q4 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 2 closing their positions.
0.45% less ownership
Funds ownership: 1.09% → 0.64% (-0.45%)
40% less funds holding
Funds holding: 5 → 3 (-2)
49% less capital invested
Capital invested by funds: $36K → $18.3K (-$17.6K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$8.07K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$6.67K |
NXL Hedge Fund Activity: Q4 2023 in Review
3 of the 6,869 institutional investors tracked by Wall St. Rank reported a position in Nexalin Technology (NXL) for Q4 2023, worth a combined $18.3K — down 49% from $36K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of NXL and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Susquehanna International Group, exiting entirely with an estimated $8.07K sold.
- 3 institutional investors held Nexalin Technology (NXL) as of Q4 2023, down from 5 in Q3 2023.
- Funds reported $18.3K of Nexalin Technology stock for Q4 2023, down 49% quarter-over-quarter.
- 0 funds opened new Nexalin Technology positions in Q4 2023 and 2 closed out, a net change of -2 holders.
- The largest Nexalin Technology seller in Q4 2023 was Susquehanna International Group, an estimated $8.07K sold.
Based on aggregated 13F filings for Q4 2023.